Nautilus Biotechnology (NAUT) Non-Current Assets (2020 - 2026)

Nautilus Biotechnology (NAUT) has 7 years of Non-Current Assets data on file, last reported at $78.9 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Assets fell 8.3% year-over-year to $78.9 million; the trailing twelve-month figure through Mar 2026 stood at $293.2 million (down 29.07% YoY), and the FY2025 full-year result was $85.1 million, down 22.53% from the prior year.
• Non-Current Assets declined to $78.9 million in Q1 2026, from $85.1 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $175.4 million in Q1 2023 to a low of $57.6 million in Q1 2022.
• A 5-year average of $105.7 million and a median of $101.8 million in 2024 frame the typical range for Non-Current Assets.
• Peak annual rise in Non-Current Assets reached 266.07% in 2022, while the deepest fall reached 61.48% in 2022.
• Tracing NAUT's Non-Current Assets over 5 years: stood at $162.8 million in 2022, then declined by 20.95% to $128.7 million in 2023, then slipped by 14.61% to $109.9 million in 2024, then fell by 22.53% to $85.1 million in 2025, then declined by 7.28% to $78.9 million in 2026.
• Business Quant data shows NAUT's Non-Current Assets at $78.9 million in Q1 2026, $85.1 million in Q4 2025, and $66.6 million in Q3 2025.